These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 11786974)

  • 1. Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis.
    Angelico M; Di Paolo D; Trinito MO; Petrolati A; Araco A; Zazza S; Lionetti R; Casciani CU; Tisone G
    Hepatology; 2002 Jan; 35(1):176-81. PubMed ID: 11786974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients.
    Stärkel P; Stoffel M; Lerut J; Horsmans Y
    Liver Transpl; 2005 Oct; 11(10):1228-34. PubMed ID: 16184571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended double-dosage HBV vaccination after liver transplantation is ineffective, in the absence of lamivudine and prior wash-out of human Hepatitis B immunoglobulins.
    Di Paolo D; Lenci I; Trinito MO; Carbone M; Longhi C; Tisone G; Angelico M
    Dig Liver Dis; 2006 Oct; 38(10):749-54. PubMed ID: 16916630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: report of two successful cases.
    Di Paolo D; Lenci I; Trinito MO; Tisone G; Angelico M
    Dig Liver Dis; 2005 Oct; 37(10):793-8. PubMed ID: 16024302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBV vaccination in liver transplant recipients: not an effective strategy in the prophylaxis of HBV recurrence.
    Karasu Z; Ozacar T; Akarca U; Ersoz G; Erensoy S; Gunsar F; Kobat A; Tokat Y; Batur Y
    J Viral Hepat; 2005 Mar; 12(2):212-5. PubMed ID: 15720538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B.
    Lo CM; Liu CL; Chan SC; Lau GK; Fan ST
    J Hepatol; 2005 Aug; 43(2):283-7. PubMed ID: 15964658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration.
    Rosenau J; Kreutz T; Kujawa M; Bahr MJ; Rifai K; Hooman N; Finger A; Michel G; Nashan B; Kuse ER; Klempnauer J; Tillmann HL; Manns MP
    J Hepatol; 2007 Apr; 46(4):635-44. PubMed ID: 17316869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
    Wang SH; Loh PY; Lin TL; Lin LM; Li WF; Lin YH; Lin CC; Chen CL
    Liver Transpl; 2017 Oct; 23(10):1266-1272. PubMed ID: 28691231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation.
    Rosenau J; Hooman N; Hadem J; Rifai K; Bahr MJ; Philipp G; Tillmann HL; Klempnauer J; Strassburg CP; Manns MP
    Liver Transpl; 2007 Mar; 13(3):367-73. PubMed ID: 17318859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
    Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
    Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression.
    Lenci I; Baiocchi L; Tariciotti L; Di Paolo D; Milana M; Santopaolo F; Manzia TM; Toti L; Svicher V; Tisone G; Perno CF; Angelico M
    Liver Transpl; 2016 Sep; 22(9):1205-13. PubMed ID: 27272189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation.
    Gane EJ; Angus PW; Strasser S; Crawford DH; Ring J; Jeffrey GP; McCaughan GW;
    Gastroenterology; 2007 Mar; 132(3):931-7. PubMed ID: 17383422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease.
    Bienzle U; Günther M; Neuhaus R; Vandepapeliere P; Vollmar J; Lun A; Neuhaus P
    Hepatology; 2003 Oct; 38(4):811-9. PubMed ID: 14512868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis.
    Roche B; Feray C; Gigou M; Roque-Afonso AM; Arulnaden JL; Delvart V; Dussaix E; Guettier C; Bismuth H; Samuel D
    Hepatology; 2003 Jul; 38(1):86-95. PubMed ID: 12829990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to vaccination against hepatitis B virus with a schedule of four 40-μg doses in cirrhotic patients evaluated for liver transplantation: factors associated with a response.
    Gutierrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martin JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
    Transplant Proc; 2012; 44(6):1499-501. PubMed ID: 22841195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year vaccination against hepatitis B virus with a MPL-vaccine in liver transplant patients for HBV-related cirrhosis.
    Di Paolo D; Lenci I; Cerocchi C; Tariciotti L; Monaco A; Brega A; Lotti L; Tisone G; Angelico M
    Transpl Int; 2010 Nov; 23(11):1105-12. PubMed ID: 20492620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation.
    Sánchez-Fueyo A; Rimola A; Grande L; Costa J; Mas A; Navasa M; Cirera I; Sánchez-Tapias JM; Rodés J
    Hepatology; 2000 Feb; 31(2):496-501. PubMed ID: 10655276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis of recurrent hepatitis B virus by vaccination after liver transplant: preliminary results.
    Albeniz Arbizu E; Barcena Marugan R; Oton Nieto E; Carrera Alonso E; Garcia Gonzalez M; Moreno Garcia J; de Vicente Lopez E; Nuño Vazquez-Garza J; Martin Davila P
    Transplant Proc; 2003 Aug; 35(5):1848-9. PubMed ID: 12962820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
    Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
    Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.